Antibiotic Treatment Guidelines

Recommended Antibiotic Regimens

The Infectious Diseases Society of America recommends carbapenems (e.g., ertapenem, meropenem, imipenem-cilastatin) as treatment options for certain infections 1
Moxifloxacin 400 mg daily is recommended for community-acquired intra-abdominal infections 2
The Infectious Diseases Society of America suggests metronidazole + third-generation cephalosporin (e.g., ceftriaxone, cefotaxime) or fluoroquinolone (e.g., ciprofloxacin, levofloxacin) as treatment options for certain infections 1
Clindamycin + aminoglycoside is suggested as a treatment option for certain infections 1
For community-acquired, mild-moderate severity infections, single agents such as ticarcillin-clavulanate, cefoxitin, ertapenem, moxifloxacin, or tigecycline are recommended 1
For healthcare-associated or severe infections, imipenem-cilastatin, meropenem, doripenem, or piperacillin-tazobactam are recommended 1
Cefepime/ceftazidime + metronidazole is suggested as a treatment option for healthcare-associated or severe infections 1

Local resistance patterns should guide empiric therapy, particularly for Bacteroides fragilis 1
The Centers for Disease Control and Prevention (CDC) recommends considering broader spectrum antibiotics, longer duration of therapy (14 days), and close monitoring for septicemia in immunocompromised patients, especially HIV-infected individuals 3
The CDC suggests stool culture to identify specific gram-negative organisms, blood cultures if fever is present, and consideration of endoscopy if symptoms persist despite therapy in immunocompromised patients 3
The Infectious Diseases Society of America (IDSA) recommends ampicillin/sulbactam or ticarcillin/clavulanate as alternative regimens if there are contraindications to first-line therapy, with a strength of evidence based on clinical experience 4
The IDSA also recommends cefazolin/metronidazole combination as an alternative regimen, with a strength of evidence based on clinical experience 4

Metronidazole is typically combined with third/fourth-generation cephalosporins, fluoroquinolones, or aminoglycosides for comprehensive treatment of mixed infections, as recommended by the IDSA 5
Resistance to metronidazole among anaerobes remains relatively uncommon, with metronidazole having excellent activity against Bacteroides fragilis, according to the Clinical Microbiology and Infection society and the World Journal of Emergency Surgery 5, 6
Metronidazole is highly effective against obligate anaerobic bacteria, particularly anaerobic gram-negative bacilli, but has limited activity against certain anaerobic gram-positive cocci and requires combination therapy for mixed infections, with a strength of evidence rated as high 7, 8, 6
The presence of Enterococcus faecalis can reduce metronidazole's effectiveness against Bacteroides species in mixed infections, emphasizing the need for appropriate gram-positive coverage when treating polymicrobial infections, with a strength of evidence rated as high 8

The American Gastroenterological Association recommends considering probiotics during and after antibiotic therapy to reduce the risk of C. difficile infection, with a moderate strength of evidence 9
The CDC and the European Society of Clinical Microbiology and Infectious Diseases suggest considering fecal microbiota transplantation (FMT) for recurrent or persistent cases, though evidence is limited 9, 10
The CDC recommends repeat stool analysis 2 weeks after completing antibiotics, and considering alternative diagnoses, resistant organisms, or underlying conditions affecting the gut microbiome if symptoms persist 3
Clindamycin is often a better choice when anaerobic coverage that includes gram-positive cocci is needed, with a strength of evidence rated as high 8

The IDSA and the American College of Surgeons suggest that metronidazole is often used in combination with other agents for the treatment of intra-abdominal infections, including peritonitis and intra-abdominal abscesses 5, 6
The World Journal of Emergency Surgery and the IDSA recommend combining metronidazole with agents that cover gram-positive and gram-negative aerobic organisms for intra-abdominal infections, with a strength of evidence rated as moderate 7, 4, 1, 6
For diabetic foot infections, the International Working Group on the Diabetic Foot recommends metronidazole as part of the regimen, combined with agents covering other pathogens when anaerobic coverage is needed 11